Silence Therapeutics Plc Adr (SLN)

Jul 21, 2025

Wall Street Analysts Believe GH Research (GHRS) Could Rally 107.25%: Here's is How to Trade - Yahoo.co

Jul 21, 2025

Jul 02, 2025

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jul 02, 2025

Jun 23, 2025

Beat the Market the Zacks Way: Credo, Palantir, Oracle in Focus - Zacks Investment Research

Jun 23, 2025

Jun 20, 2025

Silence Therapeutics soars 67% following InvestingPro’s Fair Value signal By Investing.com - Investing.com

Jun 20, 2025

Jun 13, 2025

H.C. Wainwright reiterates buy rating on Silence Therapeutics stock By Investing.com - Investing.com South Africa

Jun 13, 2025

Jun 08, 2025

Wall Street Analysts Think Silence Therapeutics (SLN) Could Surge 556.19%: Read This Before Placing a Bet - MSN

Jun 08, 2025

May 24, 2025

Silence Therapeutics’s SWOT analysis: gene therapy stock faces pivotal year By Investing.com - Investing.com India

May 24, 2025

May 24, 2025

Silence Therapeutics’s SWOT analysis: gene therapy stock faces pivotal year - Investing.com

May 24, 2025

May 22, 2025

Wall Street Analysts Believe Silence Therapeutics (SLN) Could Rally 590.66%: Here's is How to Trade - MSN

May 22, 2025

Mar 31, 2025

Silence Therapeutics stock hits 52-week low at $3.19 By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Silence Therapeutics stock hits 52-week low at $3.19 - Investing.com

Mar 31, 2025

Mar 21, 2025

Silence Therapeutics (SLN) Upgraded to Buy: Here's What You Should Know - MSN

Mar 21, 2025

Mar 20, 2025

Silence Therapeutics stock hits 52-week low at $3.66 amid downturn - Investing.com

Mar 20, 2025

Mar 20, 2025

Silence Therapeutics stock hits 52-week low at $3.66 amid downturn By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 18, 2025

Taiwan Semiconductor Valuation: How Realistic Is the Price? - The Globe and Mail

Mar 18, 2025

Mar 13, 2025

Silence Therapeutics stock hits 52-week low at $4.04 amid challenges - Investing.com

Mar 13, 2025

Mar 13, 2025

Silence Therapeutics stock hits 52-week low at $4.04 amid challenges By Investing.com - Investing.com South Africa

Mar 13, 2025

Feb 27, 2025

Earnings call transcript: Silence Therapeutics sees stock rise post-earnings - Investing.com

Feb 27, 2025

Feb 20, 2025

BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment - GlobeNewswire Inc.

Feb 20, 2025

Feb 11, 2025

Goldman Sachs cuts Silence Therapeutics stock rating to Sell By Investing.com - Investing.com South Africa

Feb 11, 2025

Feb 11, 2025

Should investors be concerned about Silence Therapeutics Plc ADR (SLN)? - US Post News

Feb 11, 2025

Feb 11, 2025

Akoya Biosciences Inc (AKYA)’s Day in Review: Closing at 2.34, Down by -4.88 - The Dwinnex

Feb 11, 2025

Feb 10, 2025

Cloudflare Inc’s (NET) Stock: A 29.10% Simple Moving Average for the Past 20 Days - The News Heater

Feb 10, 2025

Feb 03, 2025

Silence Therapeutics's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa

Feb 03, 2025

Feb 03, 2025

Silence Therapeutics's SWOT analysis: stock poised for growth amid challenges - Investing.com

Feb 03, 2025

Feb 03, 2025

H.C. WAINWRIGHT MAINTAINS $75 TARGET ON SILENCE THERAPEUTICS STOCK By Investing.com - Investing.com South Africa

Feb 03, 2025

Dec 18, 2024

Top 3 Health Care Stocks That May Explode In Q4 - Benzinga

Dec 18, 2024

Nov 20, 2024

SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels - Nasdaq

Nov 20, 2024

Nov 19, 2024

Silence Therapeutics weakness after AHA updates ‘overdone,’ says BMO Capital - Nasdaq

Nov 19, 2024

Jun 20, 2024

Zerlasiran shows promise in phase 2 study for cardiovascular risk - Investing.com India

Jun 20, 2024

Feb 28, 2024

Silence Therapeutics PLC Sponsored ADR (SLN) Soars 6.4%: Is Further Upside Left in the Stock? - Yahoo Finance

Feb 28, 2024

Jan 31, 2024

Silence Therapeutics to Join Guggenheim Biotech Conference By Investing.com - Investing.com India

Jan 31, 2024

Dec 15, 2023

Here's Why Momentum in Silence Therapeutics PLC Sponsored ADR (SLN) Should Keep going - Nasdaq

Dec 15, 2023

Nov 01, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 01, 2023

Sep 19, 2023

BioCryst (BCRX) Surges 9.9%: Is This an Indication of Further Gains? - Nasdaq

Sep 19, 2023

Jun 01, 2023

Claire Keast-Butler - Cooley

Jun 01, 2023

Apr 21, 2023

Our approach to nucleotide-based therapeutics - AstraZeneca

Apr 21, 2023

Jan 18, 2023

5 Stocks to Buy as the Drug Industry Bets Big on Innovation - Nasdaq

Jan 18, 2023

Jan 04, 2023

Silence Therapeutics PLC Sponsored ADR (SLN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance

Jan 04, 2023

Dec 30, 2020

Genfit (NASDAQ:GNFT) Stock Quotes, Forecast and News Summary - Benzinga

Dec 30, 2020

Oct 21, 2020

SLN News Today | Why did Silence Therapeutics stock go up today? - MarketBeat

Oct 21, 2020

Oct 21, 2020

Silence Therapeutics (SLN) Stock Price, News & Analysis - MarketBeat

Oct 21, 2020

Dec 14, 2017

Silence Therapeutics (SLN) - Zacks Investment Research

Dec 14, 2017